Arkis BioSciences
Knoxville, US · Founded 2016 · Delaware corporation
Founders & leadership
QA
Quentin AtenNamed on SEC filing
JA
James A. Killeffer, M.D.Named on SEC filing
KW
Ken WoodyNamed on SEC filing
CE
Chad E. SeaverNamed on SEC filing
CM
Clif MoyersNamed on SEC filing
SA
Stephen ArnoldNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7.8M disclosed across 2 rounds · 2016–2018
▶$3.4MraisedAug 2018 · 8 investors · BiotechnologyRule 506(b)
▶$3.4MraisedAug 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chad E. SeaverExecutive Officer, Director
- Ken WoodyDirector
- Quentin AtenExecutive Officer
- Clif MoyersDirector
- Stephen ArnoldExecutive Officer
- James A. Killeffer, M.D.Executive Officer, Director
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$4.5MraisedAug 2018 · 25 investors · BiotechnologyRule 506(b)
▶$4.5MraisedAug 2018 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Quentin AtenExecutive Officer
- James A. Killeffer, M.D.Executive Officer, Director
- Ken WoodyDirector
- Chad E. SeaverExecutive Officer, Director
- Clif MoyersDirector
- Stephen ArnoldExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Arkis BioSciences raised?
- Arkis BioSciences has disclosed $7.8M raised across 2 rounds.
- Where is Arkis BioSciences headquartered?
- Arkis BioSciences is headquartered in Knoxville, US.